FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283814979> ?p ?o ?g. }

• W4283814979 abstract "Background Cellular immunodeficiency and comorbidities are common in COVID-19 patients. Aim The purpose of this study was to investigate comorbidities impacting on the cellular immunity in COVID-19 patients. Methods The research objects included 55 healthy controls and 718 COVID-19 patients who divided into the control group and the COVID-19 group, respectively. Those in the COVID-19 group were divided into subgroups on the basis of the number and types of comorbidities present. Lymphocyte itself and its subsets were compared between the control group and the COVID-19 group, the groups with comorbidities based on the different number and types of comorbidities, and the relationship between the lymphocyte counts and subsets with the number and types of comorbidities was investigated. Results Compared with the control group, the lymphocyte counts and T cell subsets were significantly increased in the groups with comorbidities, but both B and NK cell subsets were significantly decreased in the no comorbidity group and in most of the groups with comorbidities (all P&lt;0.05). In the three comorbidities group, the lymphocyte counts and T cell subsets were all significantly decreased, but the CD56+ percentage was obviously increased (all P&lt;0.05). The number of comorbidities was negatively correlated with the lymphocyte counts and the T and NK cell subsets. A negative correlation also existed between cancer and both the lymphocyte counts and the T cell subsets, between chronic hepatitis B and the lymphocyte counts, and between chronic kidney disease and the CD3+ counts. A positive correlation existed between nonalcoholic fatty liver disease (NAFLD) disease and both lymphocyte and CD3+ counts. The risk factors were number of comorbidities for the lymphocyte count, CD3+CD4+ and CD3+CD8+ percentages, NAFLD for the lymphocyte and CD3+ counts, cardiovascular diseases for CD3+CD4+ and CD3+CD8+ percentages, diabetes mellitus for the CD3+CD8+ percentage, and cancer for the CD3+ percentage, respectively. Conclusions High numbers of comorbidities and specific comorbidities could impact the immune response of COVID-19 patients. This study provides a reference for clinicians in the identification of suitable and timely immunotherapy for COVID-19 patients. Clinical Trial Registry https://www.chictr.org.cn/enindex.aspx , identifier ChiCTR2000034563." @default.
• W4283814979 created "2022-07-06" @default.
• W4283814979 creator A5014353650 @default.
• W4283814979 creator A5028296024 @default.
• W4283814979 creator A5030498851 @default.
• W4283814979 creator A5036554198 @default.
• W4283814979 creator A5044364019 @default.
• W4283814979 creator A5058201449 @default.
• W4283814979 creator A5059435565 @default.
• W4283814979 creator A5088388596 @default.
• W4283814979 date "2022-07-05" @default.
• W4283814979 modified "2023-09-30" @default.
• W4283814979 title "High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients" @default.
• W4283814979 cites W1981904722 @default.
• W4283814979 cites W1996424780 @default.
• W4283814979 cites W2004409501 @default.
• W4283814979 cites W2023419926 @default.
• W4283814979 cites W2024138646 @default.
• W4283814979 cites W2070463916 @default.
• W4283814979 cites W2138927183 @default.
• W4283814979 cites W2179644821 @default.
• W4283814979 cites W2297634434 @default.
• W4283814979 cites W2790127336 @default.
• W4283814979 cites W2808782057 @default.
• W4283814979 cites W2910109445 @default.
• W4283814979 cites W2911146993 @default.
• W4283814979 cites W2951410274 @default.
• W4283814979 cites W2979371456 @default.
• W4283814979 cites W2999318660 @default.
• W4283814979 cites W3000771439 @default.
• W4283814979 cites W3001118548 @default.
• W4283814979 cites W3001897055 @default.
• W4283814979 cites W3002108456 @default.
• W4283814979 cites W3003217347 @default.
• W4283814979 cites W3005196371 @default.
• W4283814979 cites W3008491765 @default.
• W4283814979 cites W3008827533 @default.
• W4283814979 cites W3009859788 @default.
• W4283814979 cites W3011305849 @default.
• W4283814979 cites W3013125498 @default.
• W4283814979 cites W3023787531 @default.
• W4283814979 cites W3035029466 @default.
• W4283814979 cites W3038063455 @default.
• W4283814979 cites W3042059973 @default.
• W4283814979 cites W3044273501 @default.
• W4283814979 cites W3080083648 @default.
• W4283814979 cites W3096689004 @default.
• W4283814979 cites W3110951553 @default.
• W4283814979 cites W3118739191 @default.
• W4283814979 cites W3165656738 @default.
• W4283814979 cites W3210175544 @default.
• W4283814979 cites W4206667770 @default.
• W4283814979 doi "https://doi.org/10.3389/fimmu.2022.899930" @default.
• W4283814979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35865540" @default.
• W4283814979 hasPublicationYear "2022" @default.
• W4283814979 type Work @default.
• W4283814979 citedByCount "7" @default.
• W4283814979 countsByYear W42838149792022 @default.
• W4283814979 countsByYear W42838149792023 @default.
• W4283814979 crossrefType "journal-article" @default.
• W4283814979 hasAuthorship W4283814979A5014353650 @default.
• W4283814979 hasAuthorship W4283814979A5028296024 @default.
• W4283814979 hasAuthorship W4283814979A5030498851 @default.
• W4283814979 hasAuthorship W4283814979A5036554198 @default.
• W4283814979 hasAuthorship W4283814979A5044364019 @default.
• W4283814979 hasAuthorship W4283814979A5058201449 @default.
• W4283814979 hasAuthorship W4283814979A5059435565 @default.
• W4283814979 hasAuthorship W4283814979A5088388596 @default.
• W4283814979 hasBestOaLocation W42838149791 @default.
• W4283814979 hasConcept C126322002 @default.
• W4283814979 hasConcept C167672396 @default.
• W4283814979 hasConcept C203014093 @default.
• W4283814979 hasConcept C2777761686 @default.
• W4283814979 hasConcept C2778653478 @default.
• W4283814979 hasConcept C2779134260 @default.
• W4283814979 hasConcept C2779159551 @default.
• W4283814979 hasConcept C3008058167 @default.
• W4283814979 hasConcept C3017875465 @default.
• W4283814979 hasConcept C3020391436 @default.
• W4283814979 hasConcept C524204448 @default.
• W4283814979 hasConcept C71924100 @default.
• W4283814979 hasConcept C8891405 @default.
• W4283814979 hasConceptScore W4283814979C126322002 @default.
• W4283814979 hasConceptScore W4283814979C167672396 @default.
• W4283814979 hasConceptScore W4283814979C203014093 @default.
• W4283814979 hasConceptScore W4283814979C2777761686 @default.
• W4283814979 hasConceptScore W4283814979C2778653478 @default.
• W4283814979 hasConceptScore W4283814979C2779134260 @default.
• W4283814979 hasConceptScore W4283814979C2779159551 @default.
• W4283814979 hasConceptScore W4283814979C3008058167 @default.
• W4283814979 hasConceptScore W4283814979C3017875465 @default.
• W4283814979 hasConceptScore W4283814979C3020391436 @default.
• W4283814979 hasConceptScore W4283814979C524204448 @default.
• W4283814979 hasConceptScore W4283814979C71924100 @default.
• W4283814979 hasConceptScore W4283814979C8891405 @default.
• W4283814979 hasLocation W42838149791 @default.
• W4283814979 hasLocation W42838149792 @default.
• W4283814979 hasLocation W42838149793 @default.
• W4283814979 hasOpenAccess W4283814979 @default.
• W4283814979 hasPrimaryLocation W42838149791 @default.

• next